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Pennsylvania.Introduction
During orthodromic atrioventricular reentrant tachycardia
(AVRT), ventricles are activated anterogradely through the
atrioventricular node and retrogradely through an accessory
pathway (AP). Antiarrhythmic drugs are initially used to
prevent recurrences1,2 of AVRT, whereas catheter ablation is
frequently performed as a deﬁnitive treatment.3 Occasion-
ally, catheter ablation can be “proarrhythmic” if the AP is
partially damaged but not completely eliminated.4 A similar
proarrhythmic effect has not been described with antiar-
rhythmic drugs in patients with an AP. In fact, the literature
only describes the proarrhythmic effect of ﬂecainide causing
atrial ﬂutter or ventricular tachycardia,5,6 but not the devel-
opment of incessant supraventricular tachycardia in subjects
with an AP. In the present report we describe a patient with
Wolff-Parkinson-White syndrome due to a right paraseptal
AP in whom the administration of ﬂecainide resulted in an
incessant form of AVRT resembling the permanent form of
junctional reciprocating tachycardia.Case report
A 16-year-old male subject with a structurally normal heart
and a manifest right-sided AP consistent with a paraseptal
location5 (Figure 1A) presented with recurrent palpitations.
A supraventricular tachycardia was documented with a cycle
length of 220 msec (Figure 2A). Initial treatment with beta
blocker was ineffective in preventing recurrence of theKEYWORDS Supraventricular tachycardia; Wolff-Parkinson-White syndrome;
Flecainide; Incessant orthodromic AV reentrant tachycardia; Proarrhythmia
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).tachycardia. He was then started on ﬂecainide (50 mg every
12 hours). One week later, he had no recurrence of tachycardia
and the electrocardiogram showed disappearance of ventric-
ular preexcitation (Figure 1B). By performing carotid sinus
massage and asking the patient to exercise, long and short
sinus cycle lengths were obtained and conﬁrmed that ante-
grade block over the AP was present over a wide range of
sinus cycle lengths. Unexpectedly, 1 month after initiation of
ﬂecainide, he developed an incessant supraventricular tachy-
cardia. When compared with the tachycardia observed before
ﬂecainide administration, under the drug the cycle length had
now increased, from 220 to 320 msec, and the RP interval had
increased from 80 to 120 msec (Figure 2B). Clear retrograde P
waves were observed in inferior leads. Administration of
repeated doses of adenosine (6-12-24 mg) only terminated the
tachycardia transiently, with rapid reinitiation of the arrhyth-
mia in the absence of atrial or ventricular premature beats
(Figure 2C). In fact, a slight shortening of the PP interval was
enough to reinitiate that tachycardia without a premature
atrial or ventricular beat, resembling the permanent form of
junctional reciprocating tachycardia. The supraventricular
tachycardia was eventually terminated with intravenous
amiodarone administration. The patient subsequently under-
went an electrophysiology study after all antiarrhythmic drugs
had been discontinued (Figure 3), which conﬁrmed the
presence of a single AP with earliest ventricular activation
recorded close to the anterior edge of the coronary sinus
ostium. Orthodromic AVRT utilizing the AP as the retrograde
limb was induced. Delivery of radiofrequency energy at this
site eliminated AP conduction and the tachycardia could not
be reinduced.
Discussion
In the present case, adenosine was initially successful in
interrupting AVRT. However, once the electrophysiologicalpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Flecainide administration in a patient with Wolff-
Parkinson-White syndrome and atrioventricular
reentrant tachycardia resulted in suppression of
antegrade conduction over the accessory pathway
with slowing of retrograde conduction, creating
the conditions for an incessant orthodromic
atrioventricular reentrant tachycardia.
 The present case illustrates the differential
suppressive effect of antiarrhythmic agents over
antegrade vs retrograde conduction of accessory
pathways.
 This was a proarrhythmic effect of ﬂecainide
associated with development of incessant
supraventricular tachycardia.
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developed an incessant tachycardia resembling the perma-
nent form of junctional reentrant tachycardia,7 which is
secondary to an AP that only conducts retrogradely with
slow conduction, providing the conditions of a stable reentry.
One unique characteristic of the permanent form of junc-
tional reentrant tachycardia is that upon occasional termi-
nation, the arrhythmia is rapidly reinitiated after a slight
shortening of the sinus cycle length, in the absence of atrial
or premature beats. This distinctive behavior was observed inFigure 1 A: The 12-lead surface electrocardiogram before ﬂecainide.B:Disappe
of ﬂecainide.the present case during ﬂecainide administration, once the
drug had eliminated antegrade conduction over the acces-
sory A-V pathway and slowed, without abolishing, retro-
grade AP conduction, creating the conditions for an incessant
tachycardia.
Our ﬁndings of preferential loss of antegrade conduction
over the AP, with prolongation of the V-A interval during
tachycardia, are consistent with the ﬁndings of Neuss et al.8
These investigators showed that ﬂecainide abolished ante-
grade conduction over the AP in 7 out of 12 patients. In
contrast, retrograde conduction was eliminated in only 1
patient. In the present case, ﬂecainide abolished antegrade
conduction over the AP. The longer RP during tachycardia
suggests that this drug slowed retrograde conduction, result-
ing in an incessant AVRT. However, because the electro-
physiology study was performed after all antiarrhythmic
drugs were discontinued, we cannot entirely rule out an
alternative mechanism. Although previous cases of incessant
AVRT had been reported in the literature, they are not related
to ﬂecainide or other class Ic antiarrhythmic agents as in the
case herein presented. Littmann and Saxonhouse reported a
case of incessant AVRT induced by the administration of
metoprolol and diltiazem in a patient with a concealed left-
sided AP.9 In that case, these drugs slowed antegrade
conduction over the AV node, facilitating retrograde con-
duction over the AP. In contrast, in the case now presented,
ﬂecainide blocked antegrade conduction while only slowing
retrograde conduction over the AP, creating the conditions
for an incessant tachycardia.arance of antegrade conduction through the accessory pathway after the onset
Figure 2 A: Supraventricular tachycardia before administration of ﬂecainide with cycle length of 220 msec and interval RP of 80 msec. B: Incessant
supraventricular tachycardia developed during ﬂecainide administration. The RP interval has now increased to 120 msec. C: Following administration of
intravenous adenosine there was transient termination of the tachycardia with rapid reinitiation in the absence of atrial or ventricular premature beats. Shortening
of the sinus cycle length from 940 to 790 msec was enough to restart the tachycardia in the absence of premature beats. Arrows point to the retrograde P waves.
Dotted lines indicate the R-P intervals.
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Figure 3 A: Electrocardiographic leads I, II, V1, and V5 are displayed along with electrograms recorded from the His bundle (HB), coronary sinus (CS), and
right ventricle (RV) at a paper speed of 50 mm/sec. Pacing from proximal CS at a cycle length of 600 msec results in full preexcitation with negative delta wave in
V1 and II consistent with a right inferior paraseptal accessory A-V pathway. After introducing a single extrastimulus with a coupling interval of 400 msec,
antegrade block over the accessory A-V pathway allows exclusive antegrade conduction over the atrioventricular (AV) node and induction of an orthodromic AV
reentrant tachycardia with a cycle length of 280 msec. B: Same recording as panel A (50 mm/sec) with fewer signals for clarity (leads V1 and V5, HB, and CS
recordings). Earliest retrograde atrial activation was recorded from the proximal coronary sinus (CSp) owing to retrograde activation through the accessory A-V
pathway.
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Heart Rhythm Case Reports, Vol 2, No 6, November 2016510Conclusion
We describe a patient with a manifest AP in whom the
administration of ﬂecainide resulted in an incessant form of
AVRT owing to a differential suppressive effect on ante-
grade and retrograde conduction over the AP. Such proar-
rhythmic effect of a class Ic drug has not been previously
described.
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